Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Clonazepam

A benzodiazepine patented in 1960 and approved in the United States in 1975: it is used for some forms of epilepsy, including childhood ones, and for panic disorder. It is regarded as a high-potency benzodiazepine. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?REM sleep behaviour disorder, in which sleepers act out their dreams with movements and words, responds well to low doses of clonazepam.

ClonazepamGo to the active ingredient →
ClonazepamActive ingredientClonazepamCat. No. P-C212-001CAS 1622-61-3
Clonazepam-d4Isotopically labelledClonazepam-d4Cat. No. P-C212-005CAS 170082-15-2

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Reference substanceClonazepam CRSEDQM code C2385000Family Clonazepam

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.